Removing Restrictions to Germline Testing
With the global cancer burden growing, is a universal germline genomic testing approach the key to more effectively combating the disease?
Emerging Tests-dtet
PGx Testing: First, Do No Harm
Recent advances in pharmacogenomic testing—and their role in ensuring safe, effective treatment selection for precision oncology
The Demand for Digital Pathology
When it comes to cancer, patients’ greatest fear is diagnostic delays—and they believe digital pathology and AI can reduce those delays
In Tough Reimbursement Climate the Promise of Value-Based Pricing Harder to Realize
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Inside the Diagnostics Industry: Labs Move Toward Rapid Diagnoses of Infections
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Shifting Cardiovascular Guidelines Focus Attention On Lab’s Role, Emerging Tests
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
With Flu Epidemic, Better Diagnostics Become Focus
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
- « Previous
- 1
- …
- 20
- 21
- 22